|
1
|
Assi LK, Wong SH, Ludwig A, Raza K, Gordon
C, Salmon M, Lord JM and Scheel-Toellner D: Tumor necrosis factor
alpha activates release of B lymphocyte stimulator by neutrophils
infiltrating the rheumatoid joint. Arthritis Rheum. 56:1776–1786.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jian S, Lin Z, Feng J, Li Y and Shen B:
BAFF-targeting therapy, a promising strategy for treating
autoimmune diseases. Eur J Pharmacol. 597:1–5. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xiao Y, Motomura S and Podack ER: APRIL
(TNFSF13) regulates collagen-induced arthritis, IL-17 production
and Th2 response. Eur J Immunol. 38:3450–3458. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shan X, Chen L, Cao M, Xu L and Zhang S:
Effects of human soluble BAFF synthesized in Escherichia
coli on CD4+ and CD8+ T lymphocytes as
well as NK cells in mice. Physiol Res. 55:301–307. 2006.PubMed/NCBI
|
|
5
|
Kothlow S, Morgenroth I, Graef Y,
Schneider K, Riehl I, Staeheli P, Schneider P and Kaspers B: Unique
and conserved functions of B cell-activating factor of the TNF
family (BAFF) in the chicken. Int Immunol. 19:203–207. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sjöstrand M, Johansson A, Aqrawi L, Olsson
T, Wahren- Herlenius M and Espinosa A: The expression of BAFF is
controlled by IRF transcription factors. J Immunol. 196:91–97.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang S, Li JY and Xu W: Role of
BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma. Crit Rev Oncol
Hematol. 91:113–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Leonardi A, Chariot A, Claudio E,
Cunningham K and Siebenlist U: CIKS, a connection to Ikappa B
kinase and stress-activated protein kinase. Proc Natl Acad Sci USA.
97:10494–10499. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin WW: TRAF3 regulates B cell survival
and IL-6 receptor signaling. PhD dissertation. University of Iowa.
doi 10.17077/etd.3jo8jplz. 2015
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X: Act1 modulates autoimmunity through
its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine.
41:105–113. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Swaidani S, Bulek K, Kang Z, Liu C, Lu Y,
Yin W, Aronica M and Li X: The critical role of epithelial-derived
Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J
Immunol. 182:1631–1640. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu L, Zepp J and Li X: Function of Act1 in
IL-17 family signaling and autoimmunity. Adv Exp Med Biol.
946:223–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Giltiay NV, Yi L, Allman D, Jørgensen TN
and Li X: The adaptor molecule Act1 regulates BAFF responsiveness
and self-reactive B cell selection during transitional B cell
maturation. J Immunol. 185:99–109. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hase H, Kanno Y, Kojima M, Hasegawa K,
Sakurai D, Kojima H, Tsuchiya N, Tokunaga K, Masawa N, Azuma M, et
al: BAFF/BLyS can potentiate B-cell selection with the B-cell
coreceptor complex. Blood. 103:2257–2265. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang L, Zhou L, Zong X, Cao X, Ji X, Gu W
and Zhang S: Characterization of the molecular structure,
expression and bioactivity of the TNFSF13B (BAFF) gene of the South
African clawed frog, Xenopus laevis. Int Immunopharmacol.
15:478–487. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Faustova M, Plestilova L, Hulejova H,
Pecha O, Mann H, Putova J, Vencovsky J, Vencovsky J, Novota P and
Krystufkova O: A7.11 genetic variation in promoter sequence of
B-cell-activating factor of the TNF family (BAFF) in patients with
idiopathic inflammatory myopathies (IIM). Ann Rheumat Dis.
72:A512013. View Article : Google Scholar
|
|
18
|
Thompson JS, Bixler SA, Qian F, Vora K,
Scott ML, Cachero TG, Hession C, Schneider P, Sizing ID, Mullen C,
et al: BAFF-R, a newly identified TNF receptor that specifically
interacts with BAFF. Science. 293:2108–2111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schneider P, Takatsuka H, Wilson A, Mackay
F, Tardivel A, Lens S, Cachero TG, Finke D, Beermann F and Tschopp
J: Maturation of marginal zone and follicular B cells requires B
cell activating factor of the tumor necrosis factor family and is
independent of B cell maturation antigen. J Exp Med. 194:1691–1097.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schiemann B, Gommerman JL, Vora K, Cachero
TG, Shulga-Morskaya S, Dobles M, Frew E and Scott ML: An essential
role for BAFF in the normal development of B cells through a
BCMA-independent pathway. Science. 293:2111–2114. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Claudio E, Brown K, Park S, Wang H and
Siebenlist U: BAFF-induced NEMO-independent processing of NF-kappa
B2 in maturing B cells. Nat Immunol. 3:958–965. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Secreto F, Manske M, Price-Troska T,
Ziesmer S, Hodge LS, Ansell SM, Cerhan JR and Novak AJ: BAFF-R
specific activation of TRAF6 and the PI3K-pathway in lymphoma B
cells. Leuk Lymphoma. 55:1884–1892. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu H, Chen S, Liu M, Xu X, Gao K, Tian A,
Ke Z, Zhang J, Zhao B and Zhang S: Molecular characterization and
evolutionary analysis of horse BAFF-R, a tumor necrosis factor
receptor related to B-cell survival. Int Immunopharmacol.
18:163–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Li YJ, Jiang WQ, Rao HL, Huang JJ,
Xia Y, Bi X, Sun P, Huang HQ, Lin TY, et al: Expression of BAFF-R,
but not BAFF, is an independent prognostic factor in diffuse large
B-cell lymphoma patients treated with R-CHOP. Ann Hematol.
94:1865–1873. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ohba H and Bakalova R: Relationships
between degree of binding, cytotoxicity and cytoagglutinating
activity of plant-derived agglutinins in normal lymphocytes and
cultured leukemic cell lines. Cancer Chemother Pharmacol.
51:451–458. 2003.PubMed/NCBI
|
|
26
|
Care MA, Cocco M, Laye JP, Barnes N, Huang
Y, Wang M, Barrans S, Du M, Jack A, Westhead DR, et al: SPIB and
BATF provide alternate determinants of IRF4 occupancy in diffuse
large B-cell lymphoma linked to disease heterogeneity. Nucleic
Acids Res. 42:7591–7610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nicholas NS, Apollonio B and Ramsay AG:
Tumor microenvironment (TME)-driven immune suppression in B cell
malignancy. Biochim Biophys Acta. 1863:471–482. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lindqvist CA and Loskog AS: T regulatory
cells in B-cell malignancy-tumour support or kiss of death?
Immunology. 135:255–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fidanza M, Seif AE, DeMicco A, Rolf N, Jo
S, Yin B, Li Y, Barrett DM, Duque-Afonso J, Cleary ML, et al:
Inhibition of precursor B-cell malignancy progression by toll-like
receptor ligand-induced immune responses. Leukemia. 30:2116–2119.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Abolhassani H, Edwards ES, Ikinciogullari
A, Jing H, Borte S, Buggert M, Du L, Matsuda-Lennikov M, Romano R,
Caridha R, et al: Combined immunodeficiency and Epstein-Barr
virus-induced B cell malignancy in humans with inherited CD70
deficiency. J Exp Med. 214:91–106. 2017. View Article : Google Scholar : PubMed/NCBI
|
